Xenon Pharmaceuticals (XENE) has released an update.
Xenon Pharmaceuticals Inc., a company dedicated to developing treatments for neurological and psychiatric disorders, will be presenting at the Bloom Burton & Co. Healthcare Investor Conference on April 16, 2024. The event, showcasing the company’s advancements and pipeline projects, will be accessible via live webcast with a replay option on Xenon’s investor website. The presentation by President and CEO Ian Mortimer aims to draw attention to Xenon’s commitment to addressing unmet medical needs in neuroscience.
For further insights into XENE stock, check out TipRanks’ Stock Analysis page.
